Enteric Disease Testing Market Industry Analysis & Forecasts to 2026

Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region – Global Forecast to 2026

Northbrook, IL — (SBWIRE) — 01/17/2022 — The enteric disease testing market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must be increased by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market with an increasing number of enteric disease controls in each step—from the raw material procurement till the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.

Download PDF Brochure

Driver: Increase in demand for convenience foods

Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to accentuate the organoleptic characteristics of food & beverages. Packaged products are also added with preservatives to improve their shelf life. With the increase in preference for convenience foods, the need for enteric disease testing is growing.

Restraint: Lack of proper regulations governing pathogen testing in the developing economies

The food industry in developing countries remains highly fragmented and is predominated by small and unorganized players, who may have not necessarily adopted proper food testing practices, leading to a greater risk of contamination. The testing of food & beverage products, such as packaged foods, dairy products, beverages, and meat products, requires proper enforcement measures, coordination between market stakeholders, and supporting infrastructure. However, many countries that are classified in the cluster of developing economies lack these factors, acting as a restraint to the testing of pathogens in food and water in these regions.

Opportunity: Technological innovations in the enteric disease testing industry

Technological advancements and innovation across the supply chain have brought about a change in the way business is conducted. The focus is on reducing the lead time, sample utilization, the overall cost of testing services offered. Cheaper, faster, and efficient computing hardware coupled with improved software, network connectivity, and advanced sensors is gaining traction in the enteric disease industry.

Challenge: High cost associated with the testing of food and water

Automated testing instruments are equipped with advanced features and functionalities and are thus priced at a premium. For example, the price for spectroscopy-based systems ranges from USD 150,000 to USD 850,000. The estimated cost for the instrument, media, and labor is also very high for some end users. Testing laboratories require many such systems, owing to which the entire capital cost investment increases significantly.

Make an Inquiry

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TUeV SUeD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

For more information on this press release visit: http://www.sbwire.com/press-releases/enteric-disease-testing-market-industry-analysis-forecasts-to-2026-1351910.htm

Media Relations Contact

Amish Keswani
Telephone: 1-888-600-6441
Email: Click to Email Amish Keswani
Web: https://www.marketsandmarkets.com/Market-Reports/enteric-disease-testing-market-139763313.html